Clinical trial
High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)
NCT00131027 · Japan Adult Leukemia Study Group, Other · Unknown status
Key facts
| NCT number | NCT00131027 |
|---|---|
| Title | High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) |
| Official title | Randomized Controlled Trial to Test Efficacy of High-Dose Methotrexate Consolidation Therapy for BCR-ABL-Negative Acute Lymphoblastic Leukemia in Adults |
| Lead sponsor | Japan Adult Leukemia Study Group, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoblastic Leukemia, Acute |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, Daunorubicin, Vincristine, Prednisolone, L-asparaginase, Cytarabine, Etoposide, Dexamethasone, Methotrexate, Mercaptopurine and 1 more |
| Enrollment | 240 |
| Start date | Sep 1, 2002 |
| Primary completion | Mar 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Aug 17, 2005 |
| Last update posted | Nov 14, 2008 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: